AUA releases guideline on salvage therapy in prostate cancer
The guideline includes 30 recommendations related to salvage therapy for patients with biochemical recurrence following primary curative treatment for prostate cancer.
Dr. Murphy on increasing diversity in cancer clinical trials
In this podcast episode, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.
Decipher prostate test receives high evidence rating in NCCN guidelines
The Decipher test is a 22-gene prognostic tool used for the risk stratification of patients with localized prostate cancer.
Dr. Schwen on focal therapies for prostate cancer
Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.
Pudendal neuromodulation system shows promise for urinary incontinence
Interim data from the study showed that at 6 months following implantation, 80% (4 of 5) of evaluable women with mixed UI experienced a complete resolution of incontinence episodes.
AUGS Clinical Consensus Statement on Postoperative Urinary Retention
Postoperative urinary retention is a common outcome after surgical procedures for pelvic organ prolapse and stress urinary incontinence.
2 Commerce Drive Cranbury, NJ 08512